Yantai zhengfang pharmaceutical co., ltd.
Yantai zhengfang pharmaceutical co., ltd. is located in the beautiful coastal city yantai economic and technological development zone, is a modern pharmaceutical enterprises.
Mainly engaged in the treatment of diabetes, cardiovascular and cerebrovascular, liver disease, antiviral drugs and other research, production and marketing.The company covers an area of 45 mu, the construction area of 30,000 square meters, the total investment of 100 million yuan, the existing 118 employees, professional and technical personnel accounted for more than 70%...
Picnic annual production capacity
Capsule annual production capacity
Granulet annual production capacity
Early-phase insulin secretion defect is a characteristic manifestation of abnormal insulin secretion pattern in type 2 diabetes mellitus patients, and insulinotropic agents have an important role in the treatment of type 2 diabetes mellitus. Coinciding with the successful entry of the new mealtime insulinotropic agent, Miglinide calcium, into the new version of the national health insurance catalog, Diabetes International invited Prof. Mou Yiming of the General Hospital of the Chinese People's Liberation Army to explain the advantages of the application and the applicable population of Miglinide calcium, and to analyze the benefits that will be provided to the patients after its entry into the health insurance.
Defective β-cell insulin secretion is one of the central aspects of the pathogenesis of type 2 diabetes. Coinciding with the successful entry of the new mealtime insulinotropic agent, Miglinide calcium, into the new version of the National Health Insurance Catalog, Diabetes International invited Prof. Zhigang Zhao of the Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, to make a professional analysis of the advantages of the action of the new insulinotropic agent from the perspective of pharmacology.
WHY CHOOSE US
Focus on scientific research
Is located in the beautiful coastal city yantai economic and technological development zone, is a modern pharmaceutical enterprises, mainly engaged in the treatment of diabetes, cardiovascular and cerebrovascular, liver disease, antiviral drugs and other research and development, production and sales.The company covers
Products and food production workshop, production workshop, tablets, granules, hard capsules (including cephalosporins), dry suspension agent (cephalosporins) and pills and other dosage forms, finished medicines, health products GMP certification and QS food certification.Production workshop equipped with purchase
Modern production workshop
Aluminum-plastic blister packaging machine and used in food producing powder packaging machine and other advanced production equipment, advanced technology, 1 billion, annual production capacity of tablets capsule 1.35 billion grains, granules, 120 million bags.
Internal institutions: Department of Pharmaceutical Inspection, Food Inspection Department, Biological Safety Inspection Department, Comprehensive Department, and Business Department. The company fully provides scientific, accurate and high -quality services to all sectors of society
If you are interested in our products, please leave your email, we will contact you as soon as possible, thank you!